| Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis T Yoshida, M Konishi, M Horinaka, T Yasuda, AE Goda, H Taniguchi, ... Biochemical and Biophysical Research Communications 375 (1), 129-133, 2008 | 186 | 2008 |
| Baicalein overcomes tumor necrosis factor–related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells H Taniguchi, T Yoshida, M Horinaka, T Yasuda, AE Goda, M Konishi, ... Cancer research 68 (21), 8918-8927, 2008 | 129 | 2008 |
| The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of doxorubicin? WM Awara, AE El-Sisi, ME El-Sayad, AE Goda Pharmacological research 50 (5), 487-498, 2004 | 87 | 2004 |
| Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice YA Haggag, MA Osman, SA El-Gizawy, AE Goda, MM Shamloula, ... Biomedicine & Pharmacotherapy 105, 215-224, 2018 | 52 | 2018 |
| Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor–related apoptosis-inducing ligand T Yasuda, T Yoshida, AE Goda, M Horinaka, K Yano, T Shiraishi, ... Molecular Cancer Research 6 (12), 1852-1860, 2008 | 47 | 2008 |
| Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole AE Goda, T Yoshida, M Horinaka, T Yasuda, T Shiraishi, M Wakada, ... Oncogene 27 (24), 3435-3445, 2008 | 43 | 2008 |
| Targeting the glyoxalase pathway enhances TRAIL efficacy in cancer cells by downregulating the expression of antiapoptotic molecules H Taniguchi, M Horinaka, T Yoshida, K Yano, AE Goda, S Yasuda, ... Molecular cancer therapeutics 11 (10), 2294-2300, 2012 | 42 | 2012 |
| Molecular mechanisms of the antitumor activity of SB225002: a novel microtubule inhibitor AE Goda, M Koyama, Y Sowa, KM Elokely, T Yoshida, BY Kim, T Sakai Biochemical pharmacology 85 (12), 1741-1752, 2013 | 32 | 2013 |
| Histone Deacetylase Inhibitors and 15-Deoxy-Δ12,14-Prostaglandin J2 Synergistically Induce Apoptosis M Koyama, Y Izutani, AE Goda, T Matsui, M Horinaka, M Tomosugi, ... Clinical Cancer Research 16 (8), 2320-2332, 2010 | 31 | 2010 |
| Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells K Yano, M Horinaka, T Yoshida, T Yasuda, H Taniguchi, AE Goda, ... International journal of oncology 38 (2), 365-374, 2011 | 28 | 2011 |
| Lipoxygenase inhibitors induce death receptor 5/TRAIL‐R2 expression and sensitize malignant tumor cells to TRAIL‐induced apoptosis T Yoshida, T Shiraishi, M Horinaka, S Nakata, T Yasuda, AE Goda, ... Cancer science 98 (9), 1417-1423, 2007 | 27 | 2007 |
| Chitosan-encapsulated niosomes for enhanced oral delivery of atorvastatin ND Fayed, AE Goda, EA Essa, GM El Maghraby Journal of drug delivery science and technology 66, 102866, 2021 | 21 | 2021 |
| The plausible mechanisms of tramadol for treatment of COVID-19 NE El-Ashmawy, AHA Lashin, KM Okasha, AMA Kamer, TM Mostafa, ... Medical Hypotheses 146, 110468, 2021 | 21 | 2021 |
| Preclinical evaluation of bortezomib/dipyridamole novel combination as a potential therapeutic modality for hematologic malignancies AE Goda, RL Erikson, T Sakai, JS Ahn, BY Kim Molecular Oncology 9 (1), 309-322, 2015 | 21 | 2015 |
| Mitigation of doxorubicin-induced cardiotoxicity by dichloroacetate: potential roles of restoration of PGC-1α/SIRT3 signaling and suppression of oxidative stress and apoptosis MF Saleh, ME Elsayad, AE Goda Eur Rev Med Pharmacol Sci 25 (21), 6573-6584, 2021 | 12 | 2021 |
| Bacteriological studies on Domiati cheese. AI El-Zayat, A Goda, E El-Bagoury, JP Dufour, S Collin, M Osman | 12 | 1995 |
| Novel in vivo potential of trifluoperazine to ameliorate doxorubicin-induced cardiotoxicity involves suppression of NF-κB and apoptosis AE Goda, AM Elenany, AE Elsisi Life Sciences 283, 119849, 2021 | 10 | 2021 |
| Enhanced in vivo targeting of estrogen receptor alpha signaling in murine mammary adenocarcinoma by nilotinib/rosuvastatin novel combination AE Goda, AE Elsisi, SS Sokkar, NM Abdelrazik Toxicology and Applied Pharmacology 404, 115185, 2020 | 9 | 2020 |
| Induction of G1 arrest by SB265610 involves cyclin D3 down-regulation and suppression of CDK2 (Thr160) phosphorylation AE Goda, RL Erikson, JS Ahn, BY Kim Anticancer research 35 (6), 3235-3243, 2015 | 5 | 2015 |
| Peroxisome proliferator-activated receptor γ ligand troglitazone and TRAIL synergistically induce apoptosis M Koyama, Y Sowa, M Horinaka, AE Goda, J Fujiwara, T Sakai Oncology Reports 31 (2), 947-954, 2014 | 5 | 2014 |
